Chlovine 250 Tablet contains Chloroquine 250mg, a widely used anti-malarial medicine effective against Plasmodium species causing malaria. It works by inhibiting parasite growth in red blood cells, helping prevent and treat acute malaria attacks as well as providing prophylactic protection.
The formulation ensures fast absorption and predictable therapeutic action, making it suitable for hospital use, outpatient care, and travel prophylaxis. Chloroquine is highly recommended in endemic regions and for patients at risk of malaria infection.
For distributors and resellers, Chlovine 250 Tablet is a high-demand anti-malarial product, consistently prescribed in hospitals, tropical disease centers, clinics, and government malaria programs. Its critical role in malaria management ensures steady movement and recurring institutional demand throughout the year.
Adding Chlovine 250 Tablet to your portfolio strengthens your anti-malarial and hospital-care segment, offering opportunities for bulk hospital supply, government tenders, private hospital chains, export markets, and third-party manufacturing. Its essential use in malaria prevention and treatment makes it a profitable and strategically important product for pharmaceutical distributors.